reuptake in the spinal cord potentiates analgesia from and James C. Eisenach. Intravenous morphine increases release centrally administered morphine (Taiwo et al. 1985) .
tions in CSF (Detweiler et al. 1993 ) and microdialysates tors on cholinergic spinal interneurons to release acetylcholine from spinal cord dorsal but not ventral horn (Klimscha et al. (ACh) . We hypothesized that this spinally released ACh would stimulate synthesis of nitric oxide (NO), and that spinally released 1995). Acetylcholine produces analgesia when administered NO after intravenous (IV) opioid injection thus would depend on spinally, an effect blocked by muscarinic receptor antagoa cascade of noradrenergic and cholinergic receptor stimulation. nists (Yaksh et al. 1985) . Furthermore, centrally adminisTo test these hypotheses, IV morphine was administered to anesthe-tered opioids increase ACh concentrations in CSF and spinal tized sheep, and neurotransmitters in dorsal horn interstitial fluid cord dorsal horn microdialysates (Bouaziz et al. 1996) , and were measured by microdialysis. IV morphine increased NE and analgesia from central opioid injection is partially reversed ACh in dorsal horn microdialysates, and these increases were inhibby spinal injection of muscarinic receptor antagonists (Dirkited by IV naloxone or cervical spinal cord transection. IV morsen and Nijhuis 1983).
phine also increased dorsal horn microdialysate concentrations of Acetylcholine stimulates synthesis of nitric oxide (NO) nitrite, a stable metabolite of NO. Increases in NE, ACh, and nitrite were antagonized by prior intrathecal injection of the a 2 -adrenergic in vascular endothelium, and it has been hypothesized that antagonist idazoxan, the muscarinic antagonist atropine, or the NO ACh similarly stimulates NO synthesis in the spinal cord synthase inhibitor N-methyl-L-arginine (NMLA). To examine the (Iwamoto and Marion 1994a; Zhuo et al. 1993) . In this concentration-dependent effects of spinal adrenergic stimulation, regard, ACh has been shown to stimulate release of a vasoreisolated rat spinal cord tissue was perfused with the a 2 -adrenergic laxant from spinal cord tissue in vitro that shares the pharmaagonist clonidine. Clonidine increased nitrite in the spinal cord cology of NO (Xu et al. 1996b) , and analgesia from intrathetissue perfusate, an effect blocked by coadministration of idazoxan, cal injection of muscarinic receptor agonists is blocked paratropine, and NMLA. These data support a previously hypothesized tially by NO synthase (NOS) inhibitors (Iwamoto and cascade of spinally released NE and ACh after systemic opioid administration. These data also suggest that spinally released NO Marion 1994a). These results suggest that spinally released plays a role in the analgesic effects of systemic opioids. In addition, NO may play a role in analgesia produced by intravenous these data imply a positive feedback whereby spinally released (IV) morphine, involving a cascade of NE and ACh. nitric oxide increases NE release and that has not previously been Although the above data would suggest that systemically described.
administered opioids may activate NOS in the spinal cord, this has not previously been investigated. In contrast, considerable evidence suggests an antagonism of opioid analgesia
by NO and a pro-nociceptive role for spinal NO. Spinally released NO has been implicated in the production of hyperOpioids produce analgesia by actions at several sites, but algesic states after neural injury or application of a chronic a major mechanism involves activation of bulbospinal inhibnoxious stimulus . Systemically itory, primarily serotonergic (Yaksh and Tyce 1979) and administered NOS inhibitors enhance, rather than inhibit, noradrenergic (Tyce and Yaksh 1981) pathways. Thus sysanalgesia from systemically administered opioids (Yamatemic or intracerebral administration of opioids increases guchi and Naito 1996). Similarly, systemically administered norepinephrine (NE) concentrations in lumbar cerebrospinal NOS inhibitors prevent the development of tolerance from fluid (CSF) (Tyce and Yaksh 1981) and microdialysates systemically administered opioids (Kolesnikov et al. 1992) . from spinal cord dorsal, but not ventral horn (Bouaziz et Although these studies support a pronociceptive effect of al. 1996). This spinally released NE produces analgesia by spinally released NO under pathological conditions and opstimulation of a 2 -adrenoceptors, because analgesia from spiposing effects of opioids and NO with systemic administranally administered NE (Howe et al. 1983) or from centrally tion, previous studies have not addressed the interaction beadministered opioids (Tseng and Tang 1989) is blocked tween systemic opioids and spinal NOS activity. by spinal injection of a-adrenergic antagonists. In addition, augmentation of synaptic NE availability by inhibition of
The purpose of the current study was to confirm, using change was defined precisely using two pieces of silica tubing in vivo microdialysis, the proposed systemic opioid-induced 
Animal preparation
The microdialysate effluent was collected every 15 min into Following animal care and use committee approval, microdialy-cooled minitubes. The first 90 min of perfusion were considered sis experiments were performed on a total of 27 ewes of mixed as the washout period, allowing for tissue recovery and were folWestern breeds (weight range, 40-50 kg). Sheep were chosen lowed by a 60-min collection (4 samples) for baseline. This was because of their larger spinal cord than rodents, allowing precise followed by intrathecal injection of saline (6 animals), 1 mg of localization of microdialysis catheters and destruction of relative idazoxan (4 animals), 1 mg of atropine (3 animals), 2 mg of less spinal cord tissue by the catheters. The animals were fasted yohimbine (3 animals), or 3 mg of NMLA (4 animals). All infor 24 h, then anesthesia was induced with ketamine (5-10 mg/ trathecal injections were made in a volume of 1 ml followed by a kg im). The trachea was intubated and anesthesia maintained with 0.5 ml saline flush. Fifteen minutes later morphine (1 mg/kg) was halothane, 1-2%, in oxygen by controlled ventilation. Polyvinyl injected intravenously. Samples then were collected every 15 min catheters were inserted into a femoral artery and vein under direct for 2 h after IV drug administration. To determine an action of vision and advanced 15 cm centrally. The animal was positioned morphine at supraspinal sites activating descending pathways, a prone and a small laminectomy was performed at the lumbosacral complete transection of the cervical spinal cord was performed in junction to expose a 1-cm diameter patch of dura. A 21-gauge four sheep at the end of the microdialysis probe insertion and 150 polyvinyl catheter was inserted under direct vision through a small min before IV morphine administration. To confirm an action of nick in the dura and advanced 25 cm cephalad so that its tip was morphine on opioid receptors, two sheep received naloxone (1 mg/ at the midthoracic level. All incisions were closed, the catheters kg IV) 15 min before morphine injection. Drug experiments were were placed in a canvas pouch sewn to the flank and the ewe was performed in a single blind manner. allowed to awaken. At least 3 days passed before the experimental study. During this time the animals received daily penicillin G Neurochemical assays (900,000 units im).
After collection, samples were fast frozen to 020ЊC and stored at 070ЊC until assay. NE concentrations were determined by high Surgical procedure pressure liquid chromatography (HPLC) with electrochemical deOn the day of the experiment, after a 24-h fast, anesthesia was tection. This method has an interassay coefficient of variation of induced with thiopentone sodium (5 mg/kg IV) and maintained õ9% for NE and an absolute detection limit of 12 fmol (Eisenach with halothane, 1-2%, during the surgical preparation. Subse-et al. 1992) . ACh concentrations were determined by a different quently during the microdialysis experiment, anesthesia was main-HPLC-electrochemical detection method, using other equipment tained with halothane, 0.5%, in oxygen by controlled ventilation than that for catecholamines. This method has an interassay coeffiand muscle relaxation with pancuronium (0.1 mg/kg IV, every 2 cient of variation of 8% and a detection limit of 50 fmol (Detweiler h) . Ventilation was adjusted to keep PaCO 2 within a normal range et al. 1993). Nitrite, a stable metabolite of NO (Salter et al. 1996) , by continuous monitoring of end tidal CO 2 and intermittent moni-was measured via a variant of the Greiss reaction with the productoring of arterial blood gas tensions. Blood pressure and heart rate tion of a fluorescent adduct (Miles et al. 1996) , with an absolute were continuously monitored via the femoral artery catheter and detection limit of 100 pmol. recorded throughout the experiment.
The animal was turned prone and a five-level, bilateral laminec-Spinal cord tissue perfusion tomy was performed in the midthoracic region, leaving the dura and portions of the dorsal spinal processes intact for stability. Six
To examine the interactions at the spinal level of noradrenergic, to 10 microdialysis probes were inserted transversely through the cholinergic, and nitrergic activation without the confounding facsuperficial dorsal spinal cord at different sites along the exposed tors of effects of compounds on blood flow or distribution to sucord. After completion of the experiment, location of the area of praspinal sites, a spinal cord perfusion method was developed. active dialysis membrane was examined for some but not all Adult male Sprague-Dawley rats were euthanized with sodium probes, by perfusion of the probes with methylene blue dye, dissec-pentobarbital (50 mg/kg ip) and the spinal cord removed. Each tion, and examination.
spinal cord was divided into two parts, then chopped in 0.5-mm slices. Tissue sections from each hemispinal cord were put into an incubation chamber surrounded by a temperature-controlled water
Microdialysis procedure
bath maintained at 37ЊC. Tissue slices were perfused continuously with a multichannel pump at 0.5 ml/min with oxygenated modified Microdialysis probes were prepared within 3 days of surgical implantation using hollow fiber bundles (Spectrum, Los Angeles, Krebs-Henseleit solution [composition (in mM) 1 -3 ) . In each case, the time course was similar with a
To determine concentration-dependent responses, spinal cord tissue chambers were assigned randomly to receive two escalating statistically significant increase in neurotransmitter at the concentrations of clonidine, separated by 10 min. Clonidine con-first sample ( 30 min ) after IV morphine injection and concentration pairs were (in M) 10 013 and 10
010
, 10 012 and 10
09
, tinued increase for 2 h after morphine injection. Microdia-10 011 and 10
08
, 10 010 and 10
07
, 10 09 and 10
06
, and 10 08 and lysate concentrations of NE, ACh, and nitrite after cervical concentrations for NE of 0.17 pmol / ml, for ACh of 9.5 fmol / ml, and for nitrite of 19 nmol / ml ) . Similarly, preDrugs treatment with IV naloxone did not affect basal concentrations of NE ( 0.27 pmol / ml ) or ACh ( 11 fmol / ml ) but Drugs for intrathecal injection were dissolved in sterile 0.9% blocked the increase in both NE ( maximum concentration saline. Atropine, clonidine, idazoxan, naloxone, NMDA, NMLA, 0.37 pmol / ml ) and ACh ( maximum concentration 15 fmol / and yohimbine were purchased from Sigma Chemical (St. Louis, ml ) after IV morphine. MO). Halothane, ketamine, pancuronium bromide, penicillin G, thiopentone sodium, and methylene blue, were obtained from Barber Veterinary Supply, Richmond, VA.
Data analysis
Data are presented as means { SE if normally distributed and as median { 25th and 75th percentiles if not normally distributed. Within groups values of nitrite, ACh or NE were compared with baseline by one-way Kruskal-Wallis analysis of variance (AN-OVA) on ranks followed by Dunnett's test. The groups were compared with these variables by two-way nonparamentric ANOVA followed by Newman-Keuls test. P õ 0.05 was considered statistically significant.
R E S U L T S

Microdialysis studies
All animals recovered normally from intrathecal catheter insertion, and none exhibited behavioral deficits on the day of the experiment. Arterial blood gas tensions and pH and ACh, but did in nitrite (Table 1) Intrathecal pretreatment with the muscarinic antagonist, atropine, blocked morphine-induced increases in nitrite and NE EFFECT OF A 2 -ADRENERGIC ANTAGONISTS. Idazoxan, in a in dorsal horn microdialysates (Figs. 1 and 3) . Intrathecal dose shown to antagonize the hemodynamic effects of cloni-injection of the NOS inhibitor, NMLA, blocked morphinedine in unanesthetized sheep (Eisenach and Tong 1991), induced increases in nitrite, NE, and ACh in dorsal horn blocked morphine-induced increases in ACh, nitrite, and NE microdialysates (Figs. 1-3) . (Figs. 1-3 ). To confirm that this was an action on a 2 -adrenoceptors, three animals received intrathecal injection
Spinal cord tissue perfusion studies of yohimbine, which antagonizes a 2 -adrenergic but not imidazoline receptors. Yohimbine also blocked the increase in Perfusion of spinal cord slices with clonidine produced a NE after IV morphine (Fig. 1) .
concentration-dependent increase in nitrite in perfusate, with no further increase in nitrite concentration with perfusion of clonidine at concentrations ú10 09 M (Fig. 4) , and subsequent antagonist studies were performed with pretreatment with clonidine at this concentration. Perfusion with NMDA, 10 05 M, also increased nitrite in perfusate from all chambers, as a positive test of tissue viability.
Addition of idazoxan, atropine, or NMLA antagonized clonidine-induced increases in nitrite in perfused spinal cord slices. This antagonism was first significant after 10 08 M idazoxan, 10 08 M atropine, and 10 07 M NMLA (Fig. 5) . The increase in nitrite found after clonidine was shown in control experiments to be stable during the course of the experiment.
D I S C U S S I O N
The two major findings of the current study are the increase in spinal cord microdialysate concentrations of nitrite after IV morphine administration and the blockade by idazoxan, atropine, and NMLA of increased NE in these micro- We propose that IV morphine stimulates NO synthesis in the spinal cord by an NE r ACh r NO cascade, and that NE acts on a 2 -adrenoceptors. The action of a 2 -adrenergic agonists on spinal cord nitrite was tested directly in the in vitro spinal cord perfusion experiments. Clonidine increased nitrite in this system, an action antagonized by a 2 -adrenergic, cholinergic, and NOS antagonists or inhibitors, consistent with this hypothesis.
Previous examinations of spinal NO have focused on pronociceptive actions, although there is also evidence for antinociceptive actions. For example, antinociception from supraspinal (Iwamoto and Marion 1994b) or intrathecal (Iwamoto and Marion 1994a) administration of cholinergic agonists in rats is antagonized by NOS inhibitors. Some data suggest a tonically active spinal cholinergic antinociception in rats that is dependent on local NO production in rats (Zhuo et al. 1993) . 09 M increased nitrite blocked by NOS inhibitors in sheep (Xu et al. 1996a) .
in perfusate, which was antagonized by NMLA ( top), atropine (middle), Tolerance to analgesia develops rapidly in rodents exand idazoxan (bottom). Each symbol represents the median / 75 th percentile of 6-18 chambers.
posed to opioids, and this tolerance can be prevented by NMDA antagonists (Trujillo and Akil 1991) and NOS inhibitors (Kolesnikov et al. 1992) . It has been hypothesized that 1996). The current study establishes their relationship. Lack of increase after cervical cord transection confirms the obser-activation of protein kinase C by opioids results in increased intracellular calcium availability and increased NO producvation that all noradrenergic innervation of the spinal cord originates from neurons with cell bodies rostral to the cord tion (Mao et al. 1995) . The current study provides the first direct evidence that opioid administration can increase spinal (Dahlstrom and Fuxe 1965) . Functionally, spinally released NE and ACh must participate in analgesia after systemic or NO production.
Although blockade of morphine-induced microdialysate central administration of opioids, because opioid analgesia is antagonized by spinal injection of noradrenergic (Yaksh increases in ACh and nitrite by spinal injection of the a 2 -adrenergic antagonist, idazoxan is consistent with a spinal 1979) and cholinergic (Dirksen and Nijhuis 1983) antagonists and is potentiated by spinal injection of NE reuptake NE r ACh r NO cascade, its blockade of NE increase is more difficult to explain. Classically, presynaptic a 2 -adreno- (Taiwo et al. 1985) and cholinesterase (Eisenach and Gebhart 1995) inhibitors in animals. In humans, NE reuptake ceptors inhibit the release of NE, such that NE spillover is increased by a 2 -adrenergic antagonists and diminished by inhibitors have not been injected spinally, but spinal injection of neostigmine has been shown to potentiate IV opioid agonists (Langer and Hicks 1984) . The current results confirm a previous report in sheep that spinal injection of idaanalgesia (Hood et al. 1995) .
Neuronal NOS is concentrated in the rat, sheep, and hu-zoxan diminishes, rather than enhances, morphine-stimulated NE release (Bouaziz et al. 1996) . It is possible that man spinal cord in neurons residing in the superficial dorsal horn, surrounding the central canal, and in the intermediolat-idazoxan could produce this effect by its interaction with nonadrenergic, imidazoline receptors. However, this is uneral cell column (Terenghi et al. 1993; Xu et al. 1996a) , suggesting actions of NO on sensory transduction and hemo-likely because yohimbine, which does not block imidazoline receptors, also diminished morphine-induced increases in dynamic control. We and others have hypothesized that actions of ACh in these areas of the cord are mediated in part spinal NE.
Other experiments have suggested a nontraditional interby NO synthesis (Iwamoto and Marion 1994a; Xu et al. 1996a; Zhuo et al. 1993a) . As regards hemodynamic actions, action between a 2 -adrenoceptor stimulation and NE spillover in the spinal cord. Noxious electrical stimulation in anesthespinal injection of muscarinic agonists increases preganglionic sympathetic nerve activity, blood pressure, and heart tized sheep activates descending noradrenergic pathways, as evidenced by increases in lumbar CSF NE concentrations in rate (Bhargava et al. 1982; Calaresu et al. 1990) , as does intrathecal injection of NO donors (Lee et al. 1996) . There intact, but not in spinally transected animals (Eisenach et al. 1996) . As in the current study with morphine, spinal is also considerable evidence suggesting the analgesic actions of ACh is mediated in part by NO synthesis (see be-injection of idazoxan blocked the increase in CSF NE from noxious stimulation. low). This is the first study to examine the effect of systemically If a 2 -adrenergic antagonists decrease spinal NE release, one would expect that a 2 -adrenergic agonists might increase administered opioids on the spinal synthesis of NO. IV morphine produced a clear increase in nitrite concentration, NE release. We did not examine the effects of a 2 -adrenergic agonists in the current study but previously found that spinal thought under conditions of microdialysis experiments to accurately reflect NO synthesis (Salter et al. 1996) . Block-injection of clonidine increases NE in dorsal horn microdial-subsequently NO synthesis and release. These results support functional studies demonstrating spinal noradrenergic and cholinergic mechanisms of analgesia from systemically administered opioids and suggest NO may regulate NE release, reuptake, or metabolism.
